论文部分内容阅读
本刊讯（记者申晨）国家药品监督管理局经过修订完善的《新药审批办法》和《仿制药品审批办法》即将颁布实施．这两个《办法》中对我国药品审评制度作了重大调整和改革国家药品监督管理局药品注册司负责人介绍，两个《办法》和今年的工作部署中，对药品审评机制进行调整和改革
(Reporter Shen Chen) State Pharmaceutical Administration After the revision of the “new drug approval approach” and “generic drug approval approach” will be promulgated and implemented. These two “measures” made major adjustments and reforms to China’s drug review system and introduced the person in charge of the Drug Registration Department of the State Drug Administration. In the two “measures” and this year’s work deployment, the drug review mechanism was adjusted And reform